35 generic manufacturers sign agreements with MPP to produce generic versions of Pfizer’s…
The sublicence agreements are the result of the voluntary licensing agreement signed by MPP and Pfizer in November 2021 that will…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Medicines Patent Pool
SMS Pharmaceuticals receives non-exclusive licence to manufacture and supply Molnupiravir through…
The step has been taken to increase broad access of COVID-19 treatment in 105 Low- and Middle- Income Countries (LMICs)
Biophore receives sub-licence from MPP to manufacture and market Molnupiravir
The company has received DCGI regulatory license for the Indian market, applicable for both API as well as the finished product
With Omicron, the SARS-CoV-2 virus ups the ante
VOCs like Omicron are only to be expected as the divide between the vaccine haves and have-nots, and the Global North-South,…
Pfizer to allow generic COVID pill in 95 countries
There is no patent yet on the experimental candidate PF-07321332, and ritonavir has been off-patent since last year
Gilead’s anti-viral remdesivir may be found effective against coronavirus
The company is in discussions with some of the world’s leading chemical and pharmaceutical manufacturing companies about their…